Growing prevalence of hypertension is expected to drive the growth of the Global Losartan market.
Browse 293 market Figures spread through 110 Pages and an in-depth TOC on “Global Losartan Market”
https://www.techsciresearch.com/report/losartan-market/7269.html
The Global Losartan market is segmented based on source, form, strength, distribution channel, application, end user, company, and region. Based on application, the market can be fragmented into hypertension, stroke, diabetic nephropathy, and others. The hypertension segment is expected to dominate the market in the forthcoming years on account of the rising count of patients having high blood pressure problems in the country. Based on source, the market can be categorized into in-house v/s contract manufacturing organizations. Among these, the in-house segment is expected to witness the fastest growth in the forecast period. In terms of form, the market is split into tablets and powder. Among them, the tablet segment is projected to grow at a high rate in the next five years on account of multiple benefits it provides such as ease of availability, affordable price, etc. Also, they offer faster relief from symptoms when compared to powder. This is further contributing to its fast-growing CAGR in the years to come. Based on strength, the market is segmented into 25 mg, 50 mg, 100 mg and others. Among these, the 25 mg segment is expected to dominate the market because of the higher demand and supply of these tablets. Furthermore, the market can also be segmented on the basis of distribution channel which is categorized into offline and online. The offline segment is leading the market and is expected to maintain its position in the coming years as well. The prime reason for the higher share of offline sales is due to Losartan being a prescribed medicine which is not available over the counter without the doctor’s prescription. Apart from this, the market is also segmented on the basis of end-user which is sub-segmented into adult and pediatric. The adult segment is leading the market and is expected to maintain its lead in the forecast period as well.
Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Novartis International AG, Dr. Reddy’s Laboratories Ltd., Sun Pharmaceuticals Industries Ltd., Aurobindo Pharma Ltd., Torrent Pharmaceutical Ltd., Lupin Ltd., Mylan N.V., Ipca Laboratories Limited, Macleods Pharmaceuticals Limited, Abbott Laboratories, Cadila Healthcare Limited, and others are some of the leading players operating in the Global Losartan market. Companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share and increase their geographic reach.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7269
Customers can also request for 10% free customization on this report.
“Global Losartan market is expected to witness growth during the forecast period as it is used to treat hypertensive patients with left ventricular hypertrophy. Further, it reduces the risk of stroke in patients having high blood pressure problems which is further expected to create lucrative opportunities for the market growth of the Global Losartan market over the next five years.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based India management consulting firm.
“Global Losartan Market By Source (Contract Manufacturing Organizations, In-House), By Form (Tablet, Powder), By Strength (25mg, 50mg, 100mg, Others), By Distribution Channel (Offline, Online), By Application (Hypertension, Stroke, Diabetic nephropathy, Others), By End-User (Adult, Pediatric), By Region, Forecast & Opportunities, 2026” has evaluated the future growth potential of the Global Losartan market and provides statistics and information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in the Global Losartan market.
Browse Related Reports
Global Hydroxychloroquine and Chloroquine Market By Type (Injectables & Tablets), By Route of Administration (Oral v/s Intravenous), By Strength (100mg, 250mg & 500mg), By Application (Rheumatoid Arthritis, Malaria, COVID-19, Others), By Region, Competition, Forecast & Opportunities, 2030
https://www.techsciresearch.com/report/chloroquine-and-hydroxychloroquine-market/4609.html
Global Immunosuppressants API Market By Method (Synthetic Chemistry, Peptide chemistry, Fermentation, Chromatographic purification), By Application (Autoimmune Disease, Organ Transplant), By Type (Corticosteroids, Janus Kinase Inhibitor, Calcineurin Inhibitors, mTOR Inhibitor, Others), By Product (Tablets, Capsules, Liquids, Injections), By APIs (Tacrolimus, Sirolimus, Everolimus, Mycophenolate Mofetil, Mycophenolate Sodium), By End User (Biotechnology & Biopharmaceutical Companies, CMOs, CROs, CDMOs, Others), By Region, Competition, Forecast & Opportunities, 2025
https://www.techsciresearch.com/report/immunosuppressants-api-market/4673.html
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: sales@techsciresearch.com
website : https://www.techsciresearch.com
No comments:
Post a Comment